OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
OLDAKOWSKI JOSEPH FRANK has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, OLDAKOWSKI JOSEPH FRANK is listed as VP OF FINANCE AND CONTROLLER at CLOVER HEALTH INVESTMENTS, CORP. /DE. Inside the rolling window, OLDAKOWSKI JOSEPH FRANK reported no open-market purchases and 1 open-market sale totaling $59K in CLOV.
Companies traded
Other insiders at CLOV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has OLDAKOWSKI JOSEPH FRANK made?
OLDAKOWSKI JOSEPH FRANK has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does OLDAKOWSKI JOSEPH FRANK trade?
OLDAKOWSKI JOSEPH FRANK has filed SEC Form 4 disclosures for 1 company, including CLOV.
When was OLDAKOWSKI JOSEPH FRANK's most recent SEC Form 4 filing?
OLDAKOWSKI JOSEPH FRANK's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is OLDAKOWSKI JOSEPH FRANK's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, OLDAKOWSKI JOSEPH FRANK is listed as VP OF FINANCE AND CONTROLLER.
What is OLDAKOWSKI JOSEPH FRANK's total buy and sell value in the current window?
Inside the rolling retention window, OLDAKOWSKI JOSEPH FRANK bought $0 and sold $59K based on SEC Form 4 filings.
What was OLDAKOWSKI JOSEPH FRANK's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,102 CLOV shares on 2026-06-16, worth $59K, per SEC Form 4 filings.